Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Arthritis Research & Therapy
|
April 30, 2003
Elucidation of the potential roles of matrix metalloproteinases in skeletal biology
Stephen M Krane
Amino Acids
|
April 24, 2008
The importance of proline residues in the structure, stability and susceptibility to proteolytic degradation of collagens
Stephen M Krane
The New England Journal of Medicine
|
July 19, 2002
Genetic control of bone remodeling--insights from a rare disease
Stephen M Krane
The Journal of Experimental Medicine
|
March 23, 2005
Identifying genes that regulate bone remodeling as potential therapeutic targets
Stephen M Krane
Nature Clinical Practice. Rheumatology
|
August 26, 2006
Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?
Stephen M Krane
Therapeutics and Clinical Risk Management
|
May 14, 2008
Use of zoledronic acid in the treatment of Paget's disease
Margaret Seton, Stephen M Krane
Bone
|
May 20, 2008
Matrix metalloproteinases and bone
Stephen M Krane, Masaki Inada
The Journal of Clinical Investigation
|
September 5, 2002
Targeting rheumatoid inflammation and joint destruction in the mouse
Masaki Inada, Stephen M Krane
The New England Journal of Medicine
|
May 3, 2002
Anti-TNF-alpha therapy for ankylosing spondylitis--a specific or nonspecific treatment?
Jean-Michel Dayer, Stephen M Krane
Journal of Cellular Biochemistry
|
January 22, 2005
Differential regulation of platelet-derived growth factor stimulated migration and proliferation in osteoblastic cells
Meenal Mehrotra, Stephen M Krane, Kristen Walters, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Arthritis Research & Therapy
|
April 30, 2003
Elucidation of the potential roles of matrix metalloproteinases in skeletal biology
Stephen M Krane
Amino Acids
|
April 24, 2008
The importance of proline residues in the structure, stability and susceptibility to proteolytic degradation of collagens
Stephen M Krane
The New England Journal of Medicine
|
July 19, 2002
Genetic control of bone remodeling--insights from a rare disease
Stephen M Krane
The Journal of Experimental Medicine
|
March 23, 2005
Identifying genes that regulate bone remodeling as potential therapeutic targets
Stephen M Krane
Nature Clinical Practice. Rheumatology
|
August 26, 2006
Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?
Stephen M Krane
Therapeutics and Clinical Risk Management
|
May 14, 2008
Use of zoledronic acid in the treatment of Paget's disease
Margaret Seton, Stephen M Krane
Bone
|
May 20, 2008
Matrix metalloproteinases and bone
Stephen M Krane, Masaki Inada
The Journal of Clinical Investigation
|
September 5, 2002
Targeting rheumatoid inflammation and joint destruction in the mouse
Masaki Inada, Stephen M Krane
The New England Journal of Medicine
|
May 3, 2002
Anti-TNF-alpha therapy for ankylosing spondylitis--a specific or nonspecific treatment?
Jean-Michel Dayer, Stephen M Krane
Journal of Cellular Biochemistry
|
January 22, 2005
Differential regulation of platelet-derived growth factor stimulated migration and proliferation in osteoblastic cells
Meenal Mehrotra, Stephen M Krane, Kristen Walters, et al.
Page
of 3